Medicinal Products

Lynparza

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Lynparza
Active Substance olaparib
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XK01
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od medikacijskih pogrešaka zbog uvođenja novog farmaceutskog oblika lijeka Lynparza (olaparib) 29.11.2018 AstraZeneca d.o.o.
Back